share_log

HC Wainwright & Co. Downgrades Asensus Surgical to Neutral, Lowers Price Target to $0.35

Benzinga ·  Apr 4 06:06

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Asensus Surgical (AMEX:ASXC) from Buy to Neutral and lowers the price target from $2 to $0.35.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment